The age-specific comorbidity burden of mild cognitive impairment: a US claims database study
This is my archive
Expected wait times for access to a disease-modifying Alzheimer’s treatment in England: A modelling study
A Literature Review on the Burden of Alzheimer’s Disease on Care Partners
Expected and diagnosed rates of mild cognitive impairment and dementia in the U.S. Medicare population: observational analysis
Blood-based biomarkers for Alzheimer’s disease: Current state and future use in a transformed global healthcare landscape
Preparedness of China’s health care system to provide access to a disease-modifying Alzheimer’s treatment
Expanding the use of brief cognitive assessments to detect suspected early-stage cognitive impairment in primary care
